Dr. Vito Longo is a Medical Doctor at the Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”. He has made significant contributions to the field through extensive publication records. His research interests include lung cancer, pleural mesothelioma, tobacco control and prevention, Immunotherapy, small-cell lung cancer, tumor angiogenesis, tumor microenvironement, etc. His scientific output includes 63 publications, corresponding to 1432 citations (h-index 26) (Scopus, 19 January 2024).
Dr. Annamaria Catino is a Medical Oncologist at IRCCS Istituto Tumori Giovanni Paolo II. Dr. Catino's research interests include Immunotherapy, Lung Cancer, Tobacco Control, gender differences, target therapies, etc. Dr. Catino has made significant contributions to the field through extensive publication records, and garnered widespread recognition, with numerous citations and an impressive H-index. As of 18 January 2024, Dr. Catino's works have amassed 1160 citations with an H-index of 24 in SCOPUS.
Dr. Ilaria Marech is a medical oncologist in the Diagnostic and Interventional Radiology Unit with Integrated Section of Translational Medical Oncology at National Cancer Research Center Istituto Tumori “Giovanni Paolo II” in Bari, Italy. Her research interests include tumor angiogenesis, targeted therapies, pet animal models, and ultrasonography.
Dr. Domenico Galetta is responsible for the Medical Oncology Unit for Thoracic Diseases at Clinical Cancer Center IRCCS “Giovanni Paolo II”. He provides clinical assistance for both outpatient and inpatients at the Medical Oncology Department and scientific activity research focused mainly on patients with lung and pleural cancer. He was a Fellowship at the General Pathology Institute of the University of Bari (1984-1989) and became a visiting doctor at Gustave Roussy Cancer Center (1996). His research area includes non-small cell lung cancer (NSCLC). He has made significant contributions to the field through his extensive publication record, garnered widespread recognition. He serves on several national and international scientific advisory boards, he is a member of American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), International Association for the Study of Lung Cancer (IASLC), Italian Association of Medical Oncology (AIOM), Women Against Lung Cancer in Europe (WALCE), etc. He serves as GOIM Secretary (Gruppo Oncologico Italia Meridionale) from 1994 to 2001 and from 2018 ongoing.
